Profile data is unavailable for this security.
About the company
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
- Revenue in USD (TTM)0.00
- Net income in USD-6.60m
- Incorporated2015
- Employees3.00
- LocationNLS Pharmaceutics AGThe Circle 6ZUERICH 8058SwitzerlandCHE
- Phone+41 445122150
- Fax+41 445122151
- Websitehttps://nlspharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Moleculin Biotech Inc | 0.00 | -25.17m | 7.25m | 18.00 | -- | 0.3688 | -- | -- | -11.62 | -11.62 | 0.00 | 6.91 | 0.00 | -- | -- | 0.00 | -69.24 | -46.84 | -83.35 | -51.49 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.56 | -- | -21.54 | -- |
| CeCors Inc | -100.00bn | -100.00bn | 7.31m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
| Forte Biosciences Inc | 0.00 | -35.76m | 7.48m | 11.00 | -- | 0.4405 | -- | -- | -22.03 | -22.03 | 0.00 | 11.64 | 0.00 | -- | -- | 0.00 | -124.89 | -72.06 | -170.91 | -82.27 | -- | -- | -- | -491,850.00 | -- | -- | 0.00 | -- | -- | -- | -126.79 | -- | -46.29 | -- |
| Pulmatrix Inc | 11.39m | -10.84m | 7.49m | 22.00 | -- | 0.5625 | -- | 0.6572 | -2.97 | -2.97 | 3.12 | 3.64 | 0.483 | -- | 21.64 | 517,818.20 | -45.97 | -46.91 | -52.76 | -58.12 | -- | -- | -95.18 | -238.04 | -- | -- | 0.00 | -- | 20.21 | 116.62 | 25.03 | -- | 104.29 | -- |
| GlucoTrack Inc | 0.00 | -12.05m | 7.56m | 6.00 | -- | -- | -- | -- | -2.42 | -2.42 | 0.00 | -0.6004 | 0.00 | -- | -- | 0.00 | -251.32 | -94.01 | -493.89 | -142.35 | -- | -- | -- | -10,447.96 | -- | -- | -- | -- | -- | -- | -60.02 | -- | -- | -- |
| Alterola Biotech Inc | 0.00 | -2.06m | 7.74m | 1.00 | -- | -- | -- | -- | -0.0017 | -0.0017 | 0.00 | -0.001 | 0.00 | -- | -- | 0.00 | -32.46 | -- | -46.53 | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | -- | -- | -14.64 | -- | -- | -- |
| NLS Pharmaceutics AG | 0.00 | -6.60m | 7.80m | 3.00 | -- | -- | -- | -- | -6.72 | -6.72 | 0.00 | -9.40 | 0.00 | -- | -- | 0.00 | -380.82 | -272.62 | -- | -- | -- | -- | -- | -- | -- | -27.20 | -- | -- | -- | -- | 26.21 | -- | -- | -- |
| Transcode Therapeutics Inc | 0.00 | -17.91m | 7.85m | 10.00 | -- | 2.50 | -- | -- | -75.48 | -75.48 | 0.00 | 0.182 | 0.00 | -- | -- | 0.00 | -334.48 | -133.14 | -973.00 | -181.26 | -- | -- | -- | -- | -- | -90.11 | 0.00 | -- | -- | -- | -5.59 | -- | -- | -- |
| Edesa Biotech Inc | 0.00 | -6.93m | 7.86m | 16.00 | -- | 2.74 | -- | -- | -2.21 | -2.21 | 0.00 | 0.8829 | 0.00 | -- | -- | 0.00 | -94.60 | -- | -128.81 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 52.28 | -- | -- | -- |
| BioCardia Inc | 428.00k | -8.56m | 7.91m | 16.00 | -- | -- | -- | 18.49 | -5.40 | -5.40 | 0.2636 | -0.9233 | 0.0923 | -- | 6.85 | 26,750.00 | -184.48 | -107.34 | -1,075.25 | -154.17 | -- | -- | -1,999.77 | -1,779.24 | -- | -- | -- | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
| Soligenix Inc | 494.62k | -7.04m | 7.98m | 13.00 | -- | 1.56 | -- | 16.14 | -9.58 | -9.58 | 0.6152 | 2.25 | 0.0418 | -- | 8.70 | 38,047.69 | -59.45 | -75.40 | -121.64 | -154.32 | 8.75 | 22.83 | -1,423.81 | -620.02 | -- | -- | 0.4421 | -- | -11.54 | -30.67 | 55.50 | -- | -- | -- |
| Vitro Biopharma Inc | 1.85m | -9.72m | 8.05m | 10.00 | -- | -- | -- | 4.35 | -2.18 | -2.18 | 0.4159 | -1.64 | 0.2324 | 1.58 | 24.96 | 185,140.00 | -122.00 | -- | -1,146.77 | -- | 82.88 | -- | -524.87 | -- | 0.169 | -5.37 | 5.49 | -- | -46.45 | -- | 31.01 | -- | -- | -- |
| Curative Biotechnology Inc | 0.00 | -6.02m | 8.13m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
| Virax Biolabs Group Ltd | 156.42k | -6.73m | 8.19m | 17.00 | -- | 0.964 | -- | 52.35 | -3.35 | -3.35 | 0.078 | 2.09 | 0.0205 | 3.51 | -- | 9,201.18 | -88.11 | -- | -91.88 | -- | 32.34 | -- | -4,308.35 | -- | 25.58 | -227.16 | 0.0418 | -- | 1,727.34 | -- | -23.38 | -- | -- | -- |
| Kineta Inc | 0.00 | -20.88m | 8.22m | 11.00 | -- | -- | -- | -- | -1.79 | -1.79 | 0.00 | -0.6638 | 0.00 | -- | -- | 0.00 | -220.35 | -66.16 | -- | -86.61 | -- | -- | -- | -854.74 | -- | -- | -- | -- | 178.65 | 13.89 | 77.76 | -- | -- | -- |
Data as of Nov 11 2024. Currency figures normalised to NLS Pharmaceutics AG's reporting currency: US Dollar USD
8.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BVF Partners LPas of 30 Jun 2024 | 143.68k | 5.81% |
| Armistice Capital LLCas of 30 Jun 2024 | 57.78k | 2.34% |
| UBS Securities LLCas of 30 Jun 2024 | 5.89k | 0.24% |
| Citadel Securities LLCas of 30 Jun 2024 | 3.41k | 0.14% |
| Quorus Verm�gensverwaltung AGas of 25 Sep 2024 | 2.50k | 0.10% |
| Jane Street Capital LLCas of 30 Jun 2024 | 1.09k | 0.04% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 544.00 | 0.02% |
| HRT Financial LP (US)as of 30 Jun 2024 | 421.00 | 0.02% |
| Geode Capital Management LLCas of 30 Jun 2024 | 359.00 | 0.02% |
| BofA Securities, Inc.as of 30 Jun 2024 | 2.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
